05/09/2024
8:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
7:05 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
7:41 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form DEF 14A | |
04/30/2024
7:42 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form ARS | |
04/30/2024
7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form EFFECT | |
04/17/2024
7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/16/2024
3:30 PM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
8:20 PM | NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Woodworth Marshall H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:52 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
7:45 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
8:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
8:03 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
8:20 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
4:12 PM | NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Tursi James Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:20 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:39 PM | NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Tursi James Patrick (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/30/2023
3:31 PM | NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Woodworth Marshall H (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/30/2023
7:06 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
7:03 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
3:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
7:11 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
3:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:18 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
7:15 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2023
5:02 AM | Kim Na Yeon (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
| Form 4/A | |
07/28/2023
5:08 AM | Kim Na Yeon (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
5:11 AM | Glickman Mark A (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
5:13 AM | GROVES JASON L (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
5:15 AM | NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
STRICKLAND D GORDON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
5:17 AM | NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Salsbury Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
5:19 AM | KOVEN ANDREW I (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
7:36 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
7:26 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad) Are you monitoring 13,217 cryptocurrencies everyday?
If not, you could miss the ONE that can make you wealthy beyond your wildest dreams.
You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. |
06/13/2023
7:25 AM | NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
